[HTML][HTML] Clinical and molecular markers in COPD

I Gonçalves, MJ Guimarães, M Van Zeller, F Menezes… - Pulmonology, 2018 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …

Clinical and molecular markers in COPD

I Gonçalves, MJ Guimarães, M van Zeller… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …

Clinical and molecular markers in COPD.

I Gonçalves, MJ Guimarães, M van Zeller… - …, 2018 - europepmc.org
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …

[PDF][PDF] Clinical and molecular markers in COPD

I Gonçalves, MJ Guimarães, M van Zeller, F Menezes… - therapy - scholar.archive.org
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …

[PDF][PDF] Clinical and molecular markers in COPD

I Gonçalvesa, MJ Guimarãesb, M van Zellerc… - therapy - academia.edu
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …

[PDF][PDF] Clinical and molecular markers in COPD

I Gonçalves, MJ Guimarães, M van Zeller, F Menezes… - therapy - core.ac.uk
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …

[PDF][PDF] Clinical and molecular markers in COPD

I Gonçalvesa, MJ Guimarãesb, M van Zellerc… - therapy - academia.edu
Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous disease,
and there is a clinical need for validated markers and biomarkers that can contribute to the …